Study to assess the effect of a painkiller medication (Magnesium Sulphate) on the electrical activity of the nerves
Phase 3
- Conditions
- Health Condition 1: G94- Other disorders of brain in diseases classified elsewhere
- Registration Number
- CTRI/2024/01/061199
- Lead Sponsor
- ational Institute of Mental Health and Neurosciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing elective cranial surgery who are planned for intraoperative
neuromonitoring (Somatosensory evoked potentials or motor evoked potentials or
both)
Exclusion Criteria
1. Known neuromuscular disease
2. Pregnancy
3. Cardiac conduction disorders and Ischemic Heart Disease
4. Chronic Kidney Disease
5. Refusal of consent to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method atency and amplitude of SSEP and MEPTimepoint: 1 hour during surgery
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil